Dorman Products (DORM) Earnings Analysis
Dorman Products (DORM) next reports earnings on 2026-08-03, consensus EPS 1.89 USD. Last quarter (2026-05-04) it beat with EPS 1.57 USD vs 1.52 USD est (+3.3%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E 21.62.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does DORM next report earnings?
| Next earnings date | 2026-08-03 |
|---|---|
| Consensus EPS estimate | 1.89 USD |
| Revenue estimate | 0.58B |
DORM earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-04 | 1.57 USD | 1.52 USD | +3.3% | Beat |
| 2025-10-27 | 2.62 USD | 2.31 USD | +13.4% | Beat |
| 2025-08-04 | 2.06 USD | 1.76 USD | +17% | Beat |
| 2025-05-05 | 2.02 USD | 1.48 USD | +36.5% | Beat |
| 2025-02-26 | 2.2 USD | 1.99 USD | +10.6% | Beat |
| 2024-10-31 | 1.96 USD | 1.53 USD | +28.1% | Beat |
| 2024-08-01 | 1.67 USD | 1.19 USD | +40.3% | Beat |
Beat rate: 7/7 (100%) over reported quarters with consensus data.
DORM valuation and analyst view
| Trailing P/E | 21.62 |
|---|---|
| Trailing EPS | 6.294 USD |
| Price / book | 2.78 |
| Dividend yield | 0.00% |
| Market cap | 4.04B |
| Analyst consensus | Buy (11 buy / 3 hold / 2 sell) |
| Avg price target | 165 USD |
Related research pages
Frequently asked questions
When is Dorman Products (DORM)'s next earnings date?
Dorman Products is next scheduled to report on 2026-08-03, with a consensus EPS estimate of 1.89 USD and revenue estimate of 0.58B.
Did DORM beat earnings last quarter?
In its 2026-05-04 report, DORM posted EPS of 1.57 USD versus a 1.52 USD estimate — a beat of 3.3%.
What is DORM's earnings track record?
Over the last 7 reported quarters with consensus data, DORM beat estimates 7 times (100%).
What is DORM's current P/E ratio and EPS?
DORM trades at a trailing P/E of 21.62 on trailing EPS of 6.293919142460133 USD.
What do analysts rate DORM?
Analyst consensus is "Buy" across 16 ratings (1 strong buy, 10 buy, 3 hold, 2 sell, 0 strong sell). Average 12-month price target: 165 USD.